The closing survival gap after liver transplantation for hepatocellular carcinoma in the United States
- PMID: 35981946
- DOI: 10.1016/j.hpb.2022.07.008
The closing survival gap after liver transplantation for hepatocellular carcinoma in the United States
Abstract
Background: Socio-economic inequalities among different racial/ethnic groups have increased in many high-income countries. It is unclear, however, whether increasing socio-economic inequalities are associated with increasing differences in survival in liver transplant (LT) recipients.
Methods: Adults undergoing first time LT for hepatocellular carcinoma (HCC) between 2002 and 2017 recorded in the Scientific Registry of Transplant Recipients (SRTR) were included and grouped into three cohorts. Patient survival and graft survival stratified by race/ethnicity were compared among the cohorts using unadjusted and adjusted analyses.
Results: White/Caucasians comprised the largest group (n=9,006, 64.9%), followed by Hispanic/Latinos (n=2,018, 14.5%), Black/African Americans (n=1,379, 9.9%), Asians (n=1,265, 9.1%) and other ethnic/racial groups (n=188, 1.3%). Compared to Cohort I (2002-2007), the 5-year survival of Cohort III (2012-2017) increased by 18% for Black/African Americans, by 13% for Whites/Caucasians, by 10% for Hispanic/Latinos, by 9% for patients of other racial/ethnic groups and by 8% for Asians (All P values<0.05). Despite Black/African Americans experienced the highest survival improvement, their overall outcomes remained significantly lower than other ethnic∕racial groups (adjusted HR for death=1.20; 95%CI 1.05-1.36; P=0.005; adjusted HR for graft loss=1.21; 95%CI 1.08-1.37; P=0.002).
Conclusion: The survival gap between Black/African Americans and other ethnic/racial groups undergoing LT for HCC has significantly decreased over time. However, Black/African Americans continue to have the lowest survival among all racial/ethnic groups.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Racial-ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy.Clin Transplant. 2024 Jun;38(6):e15365. doi: 10.1111/ctr.15365. Clin Transplant. 2024. PMID: 38804605
-
Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.Cancer. 2010 Mar 1;116(5):1367-77. doi: 10.1002/cncr.24817. Cancer. 2010. PMID: 20101732
-
Racial and Ethnic Differences in Liver Transplantation and Post-Liver Transplant Survival Among Patients With Hepatocellular Carcinoma.Cancer Med. 2024 Nov;13(21):e70298. doi: 10.1002/cam4.70298. Cancer Med. 2024. PMID: 39506367 Free PMC article.
-
Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.Clin Gastroenterol Hepatol. 2022 Feb;20(2):e267-e288. doi: 10.1016/j.cgh.2020.12.029. Epub 2020 Dec 30. Clin Gastroenterol Hepatol. 2022. PMID: 33387668 Free PMC article.
-
Closing the disparity gap and optimizing advanced hepatocellular carcinoma care in the hispanic community.Clin Liver Dis (Hoboken). 2022 May 27;19(6):239-243. doi: 10.1002/cld.1213. eCollection 2022 Jun. Clin Liver Dis (Hoboken). 2022. PMID: 35795623 Free PMC article. Review.
Cited by
-
Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change.JAMA Netw Open. 2023 Nov 1;6(11):e2341096. doi: 10.1001/jamanetworkopen.2023.41096. JAMA Netw Open. 2023. PMID: 37917059 Free PMC article.
-
Ethnic disparities in the epidemiology, treatment, and outcome of patients with hepatocellular carcinoma in the United States.Hepatoma Res. 2023;9:18. doi: 10.20517/2394-5079.2023.10. Epub 2023 May 18. Hepatoma Res. 2023. PMID: 38371172 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous